Intravenous immune globulin in symptomat
โ
U. B. Schaad; A. Gianella-Borradori; B. Perret; P. Imbach; A. Morell
๐
Article
๐
1988
๐
Springer
๐
English
โ 374 KB
Seven paediatric patients with symptomatic human immunodeficiency virus (HIV) infection were prospectively studied for 6-24 months after the start of intravenous immune globulin (IVIG) therapy. There was substantial clinical benefit during IVIG treatment with marked reduction of febrile and infectio